Inhibition on the S-nitrosylation of MKK4 can protect hippocampal CA1 neurons in rat cerebral ischemia/reperfusion

Brain Res Bull. 2016 Jun:124:123-8. doi: 10.1016/j.brainresbull.2016.04.005. Epub 2016 Apr 14.

Abstract

S-nitrosylation, the nitric oxide-derived post-translational modification of proteins, plays critical roles in various physiological and pathological functions. In this present study, a rat model of cerebral ischemia and reperfusion by four-vessel occlusion was generated to assess MKK4 S-nitrosylation. Immunoprecipitation and immunoblotting were performed to evaluate MKK4 S-nitrosylation and phosphorylation. Neuronal loss was observed using histological detection. These results indicated that endogenous NO promoted the S-nitrosylation of MKK4. However, application of the exogenous NO donor S-nitrosoglutathione (GNSO), an inhibitor of the neuronal nitric oxide synthase 7-nitroindazole (7-NI), and the N-methyl-d-aspartate receptor (NMDAR) antagonist MK801 diminished I/R-induced S-nitrosylation and phosphorylation. These compounds also markedly decreased cerebral I/R-induced degeneration and death of neurons in hippocampal CA1 region in rats. Taken together, we demonstrated for the first time, that cerebral ischemia/reperfusion can induce S-nitrosylation of MKK4. We also found that inhibiting S-nitrosylation and activation of MKK4 resulted in marked decreases in neuronal degeneration and apoptosis, potentially via NMDAR-mediated mechanisms. These findings may lead to a new field of inquiry to investigate the underlying pathogenesis of stoke and the development of novel treatment strategies.

Keywords: Cerebral ischemia and reperfusion (I/R); MKK4; NMDA receptor (NMDAR); Phosphorylation; S-nitrosylation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain Ischemia / drug therapy
  • Brain Ischemia / pathology*
  • CA1 Region, Hippocampal / pathology*
  • Caspase 3 / metabolism
  • Disease Models, Animal
  • Dizocilpine Maleate / therapeutic use
  • Indazoles / therapeutic use
  • MAP Kinase Kinase 4 / metabolism*
  • Male
  • Neurons / drug effects*
  • Phosphorylation / drug effects
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion*
  • S-Nitrosoglutathione / therapeutic use*
  • Time Factors

Substances

  • Indazoles
  • S-Nitrosoglutathione
  • Dizocilpine Maleate
  • MAP Kinase Kinase 4
  • Caspase 3
  • 7-nitroindazole